Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults (Q42229257)
Jump to navigation
Jump to search
scientific article published on April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults |
scientific article published on April 2014 |
Statements
1 reference
Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults (English)
1 reference
1 reference
Danielle Porter
1 reference
Calvin Cohen
1 reference
David Wohl
1 reference
Keith Henry
1 reference
Jan Van Lunzen
1 reference
Mark Bloch
1 reference
William Towner
1 reference
Edmund Wilkins
1 reference
Ramin Ebrahimi
1 reference
Kirsten White
1 reference
Ivan Walker
1 reference
Susan Chuck
1 reference
Shampa De-Oertel
1 reference
Todd Fralich
1 reference
1 April 2014
1 reference
Identifiers
1 reference